Revvity Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Revvity Inc trades at $124.14 (market cap $14.18B), while Vipshop Holdings Ltd - ADR trades at $12.8 (market cap $6.20B). The key difference: Revvity Inc is far larger — about 2.3× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.76%). Which is the better fit depends on your goals.
| RVTY | VIPS | |
|---|---|---|
Market Cap | $14.18B | $6.20B |
Sector | Technology | Consumer Cyclical |
52-Week High | $130.94 | $20.68 |
52-Week Low | $82.26 | $12.51 |
Enterprise Value | $16.50B | $3.02B |
Dividend Yield | 0.22% | 4.76% |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Vipshop Holdings trades at $13.03, down 1.29% on the day, with bearish technical signals dominating despite attractive valuation metrics. The company reported mixed Q2 2026 results with significant earnings misses, though maintains strong profitability with 9.82% net margin and 24.44% ROE. Recent institutional activity includes Nykredit A/S establishing a $2.35 million position in Q2 2026.
The stock presents a value opportunity with P/E of 4.21 and P/S of 0.41, but faces headwinds from declining revenue and challenging consumer sentiment. Analyst consensus leans bullish with 53.57% buy ratings, though technical indicators suggest near-term pressure. Key risks include Chinese consumer spending weakness and competitive pressures in e-commerce.
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →